G-744

N/A

Report date: 2022/05/24 15:09:18

NME

Base Information

Drug NameG-744

Drug Alias NameG-744

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTyrosine-protein kinase BTK inhibitors

TargetsTyrosine-protein kinase BTK

Therapy Area/IndicationsArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGenentech Inc

China Registration ClassN/A

Active CompaniesGenentech Inc

Inactive CompaniesN/A

Active IndicationsArthritis, Rheumatoid

Inactive IndicationsN/A

ATC CodeN/A